Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00050154
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2002-11-22
Brief Title:
Study of Tipifarnib in Patients With High-Risk Myelodysplastic Syndrome MDS
Sponsor:
Johnson Johnson Pharmaceutical Research Development LLC
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-05
Completion Date Type:
ACTUAL
First Submit Date:
2002-11-22
First Submit QC Date:
November 22 2002
Study First Post Date:
2002-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-04-23
Last Update Post Date:
2010-04-27
Last Update Post Date Type:
ESTIMATED